Key Takeaways QuidelOrtho's Q3 EPS of $0.80 and revenues of$699.9M beat the consensus estimate.Labs and Immunohematology units delivered solid growth, offsetting weaker respiratory sales.Adjusted operating margin rose 70 bps to 17.1%, driven by lower expenses and improved efficiency.QuidelOrtho Corporation (QDEL) delivered adjusted earnings per share (EPS) of 80 cents in third-quarter 2025 down from the year-earlier EPS of 85 cents. However, the figure surpassed the Zacks Consensus Estimate by 56.9%.The ad ...